Suchergebnisse - "Ali, Faraat"

PubPharm (35)

1

A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2024

von Sharma, A. | Rastogi, S. | Ali, F. | +2

2

In-vitro Evaluation of Triazine Scaffold for Anticancer Drug Development : A Review

enthalten in: Current drug discovery technologies | 2023

von Dubey, P. | Pathak, D. | Ali, F. | +2

3

Virosome : An engineered virus for vaccine delivery

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2023

von Ali, H. | Akbar, M. | Iqbal, B. | +9

4

Healing Potential of Propolis Extract-Passiflora edulis Seed Oil Emulgel Against Excisional Wound : Biochemical, Histopathological, and Cytokines Level Evidence

enthalten in: Assay and drug development technologies | 2022

von Gupta, P. | Singh, A. | Singh, N. | +3

5

Functional Thermoresponsive Hydrogel Molecule to Material Design for Biomedical Applications

enthalten in: Polymers | 2022

von Pardeshi, S. | Damiri, F. | Zehravi, M. | +10

6

Belumosudil with ROCK-2 inhibition : chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease

enthalten in: Current research in translational medicine | 2022

von Ali, F. | Ilyas, A.

7

Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein

enthalten in: Life (Basel, Switzerland) | 2022

von Karthika, C. | Sureshkumar, R. | Zehravi, M. | +9

8

Size-Dependent Antibacterial, Antidiabetic, and Toxicity of Silver Nanoparticles Synthesized Using Solvent Extraction of Rosa indica L. Petals

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Balu, S. | Andra, S. | Damiri, F. | +9

9

Multidrug Resistance in Cancer Cells : Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells

enthalten in: Life (Basel, Switzerland) | 2022

von Karthika, C. | Sureshkumar, R. | Zehravi, M. | +9

10

Pralsetinib : chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers

enthalten in: Archives of pharmacal research | 2022

von Ali, F. | Neha, K. | Chauhan, G.